Free Trial

Aethlon Medical Q3 2025 Earnings Report

Aethlon Medical logo
$0.35 +0.00 (+0.31%)
As of 04:00 PM Eastern

Aethlon Medical EPS Results

Actual EPS
-$0.13
Consensus EPS
-$0.22
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A

Aethlon Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aethlon Medical Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Remove Ads

Aethlon Medical Earnings Headlines

Feds Just Admitted It—They Can Take Your Cash
The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.
Aethlon Medical (AEMD) Receives a Hold from Maxim Group
See More Aethlon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aethlon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aethlon Medical and other key companies, straight to your email.

About Aethlon Medical

Aethlon Medical (NASDAQ:AEMD), a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

View Aethlon Medical Profile

More Earnings Resources from MarketBeat